Log In
Tuesday 25th June 2019

Prostate cancer hope from vaccine

20th June 2011

Scientists have said that a new way of creating vaccines to treat cancer have been used to shrink prostate tumours.


According to Nature Medicine, researchers used healthy cells to make a vaccine which successfully treated 80% of mice.

The team are hopeful that their approach might work on other types of cancer and have started tests on treatment for melanoma.

Professor Alan Melcher, of the University of Leeds, said: "The biggest challenge in immunology is developing antigens that can target the tumour without causing harm elsewhere."

The team of scientists, from the University of Leeds and the Mayo Clinic in the U.S., took pieces of DNA from healthy cells and put them into a virus.

They then injected mice with prostate tumours numerous times with the virus. They found that nine injections of the virus cured mice 80% of the time.

Professor Melcher said human trials were likely to be carried out in a few years time, rather than a few months.

"We have reason to be quite excited. It's not out-of-the-blue research, but based on immunotherpay and virus treatments which are looking very promising and that is what is really exciting," he added.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019